Evidence map›Paper›PMID 25456134›Full record

ArticleCell reports2014

FXR1P limits long-term memory, long-lasting synaptic potentiation, and de novo GluA2 translation.

Denise Cook, Erin Nuro, Emma V Jones, Haider F Altimimi, W Todd Farmer, Valentina Gandin, Edith Hanna, Ruiting Zong, Alessandro Barbon, David L Nelson and 5 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. ARL6IP1 mediates small-molecule-induced alleviation of Alzheimer pathology through FXR1-dependent BACE1 translation initiation.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

Denise Cook *Centre for Research in Neuroscience, Department of Neurology and Neurosurgery, The Research Institute of the McGill University Health Centre, Montreal General Hospital, Montreal, QC H3G 1A4, Canada.
Erin Nuro *Centre for Research in Neuroscience, Department of Neurology and Neurosurgery, The Research Institute of the McGill University Health Centre, Montreal General Hospital, Montreal, QC H3G 1A4, Canada.
Emma V JonesCentre for Research in Neuroscience, Department of Neurology and Neurosurgery, The Research Institute of the McGill University Health Centre, Montreal General Hospital, Montreal, QC H3G 1A4, Canada.
Haider F AltimimiCentre for Research in Neuroscience, Department of Neurology and Neurosurgery, The Research Institute of the McGill University Health Centre, Montreal General Hospital, Montreal, QC H3G 1A4, Canada.
W Todd FarmerCentre for Research in Neuroscience, Department of Neurology and Neurosurgery, The Research Institute of the McGill University Health Centre, Montreal General Hospital, Montreal, QC H3G 1A4, Canada.
Valentina GandinLady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital, and Department of Oncology, McGill University, Montreal, QC H3T 1E2, Canada.
Edith HannaCentre for Research in Neuroscience, Department of Neurology and Neurosurgery, The Research Institute of the McGill University Health Centre, Montreal General Hospital, Montreal, QC H3G 1A4, Canada.
Ruiting ZongDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA.
Alessandro BarbonDepartment of Molecular and Translational Medicine, National Institute of Neuroscience, University of Brescia, Brescia 25123, Italy.
David L NelsonDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA.
Ivan TopisirovicLady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital, and Department of Oncology, McGill University, Montreal, QC H3T 1E2, Canada.
Joseph RochfordDepartment of Psychiatry, Douglas Mental Health University Institute, McGill University, Verdun, QC H4H 1R3, Canada.
David StellwagenCentre for Research in Neuroscience, Department of Neurology and Neurosurgery, The Research Institute of the McGill University Health Centre, Montreal General Hospital, Montreal, QC H3G 1A4, Canada.
Jean-Claude BéïqueDepartment of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
Keith K MuraiCentre for Research in Neuroscience, Department of Neurology and Neurosurgery, The Research Institute of the McGill University Health Centre, Montreal General Hospital, Montreal, QC H3G 1A4, Canada.
McGill University Health Centre · CAMontreal General Hospital · CABaylor College of Medicine · USJewish General Hospital · CAMcGill University · CAUniversity of Ottawa · CA

Funding

Role of TNFalpha in Synaptic Homeostasis in Response to Drugs of AbuseR21DA026053 · NIDA · MCGILL UNIVERSITY · PI MURAI, KEITH KAZUO, STELLWAGEN, DAVID · 2008 to 2009
$164k
Canadian Institutes of Health Research MOP111152Canadian Institutes of Health Research MOP123390NIDA NIH HHS 1R21DA026053-01NIDA NIH HHS R21 DA026053
6 · The paper itself

Abstract

Translational control of mRNAs allows for rapid and selective changes in synaptic protein expression that are required for long-lasting plasticity and memory formation in the brain. Fragile X Related Protein 1 (FXR1P) is an RNA-binding protein that controls mRNA translation in nonneuronal cells and colocalizes with translational machinery in neurons. However, its neuronal mRNA targets and role in the brain are unknown. Here, we demonstrate that removal of FXR1P from the forebrain of postnatal mice selectively enhances long-term storage of spatial memories, hippocampal late-phase long-term potentiation (L-LTP), and de novo GluA2 synthesis. Furthermore, FXR1P binds specifically to the 5' UTR of GluA2 mRNA to repress translation and limit the amount of GluA2 that is incorporated at potentiated synapses. This study uncovers a mechanism for regulating long-lasting synaptic plasticity and spatial memory formation and reveals an unexpected divergent role of FXR1P among Fragile X proteins in brain plasticity.

Indexed as

Long-Term PotentiationMemory, Long-TermProtein Biosynthesis5' Untranslated RegionsAnimalsBehavior, AnimalMice, KnockoutReceptors, AMPARNA-Binding ProteinsRNA, MessengerSynapses5' Untranslated RegionsFxr1h protein, mouseglutamate receptor ionotropic, AMPA 2Receptors, AMPARNA-Binding ProteinsRNA, Messenger

Identifiers

PMID25456134
PMCPMC4254574
OpenAlexW1964288811

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.